Cancer chemotherapy in the older cancer patient

被引:23
作者
Carreca, Ignazio [2 ]
Balducci, Lodovico [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Senior Adult Oncol Program, Tampa, FL 33612 USA
[2] Univ Palermo, Sch Med, Palermo, Italy
关键词
Cancer; Elderly; Chemotherapy; Systemic treatment; PATIENTS RECEIVING CHEMOTHERAPY; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; MORTALITY; TOXICITY; WOMEN; RISK; ERYTHROPOIETIN; DARBEPOETIN; PREDICTION;
D O I
10.1016/j.urolonc.2009.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
This article reviews the principles of systemic cancer treatment in older individuals. These include: assessment of physiologic age with a comprehensive geriatric assessment (CGA), adjustment of chemotherapy doses to the patient's renal function, and prevention of myelotoxicity with hemopoietic growth factors. Other complications that become more common with age include mucositis, peripheral neuropathy and cardiomyopathy. Two chronic complications of chemotherapy become more common with age, including myelodysplasia and chronic cardiomyopathy. The goal of systemic cancer treatment in the older person should include prolongation of active life-expectancy and compression of morbidity in addition to prolongation of survival and symptom management. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:633 / 642
页数:10
相关论文
共 57 条
[1]
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study [J].
Aapro, Matti ;
Leonard, Robert C. ;
Barnadas, Agusti ;
Marangolo, Maurizio ;
Untch, Michael ;
Malamos, Nikolaos ;
Mayordomo, Jose ;
Reichert, Dietmar ;
Luiz Pedrini, Jose ;
Ukarma, Lidia ;
Scherhag, Armin ;
Burger, Hans-Ulrich .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :592-598
[2]
ALEKSHUN TJ, 2008, BLOOD DISORDERS ELDE, P272
[3]
Science & society - Cancer and ageing: a nexus at several levels [J].
Balducci, L ;
Ershler, WB .
NATURE REVIEWS CANCER, 2005, 5 (08) :655-662
[4]
BALDUCCI L, 2008, BLOOD DISORDERS ELDE, P120
[5]
BALDUCCI L, 2008, BLOOD DISORDERS ELDE, P225
[6]
Long overdue: Phase II studies in older cancer patients: Where does the FDA stand? [J].
Balducci, Lodovico ;
Tam-McDevitt, Jennifer ;
Hauser, Robert ;
Simon, Jody .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) :1387-1388
[7]
Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim [J].
Balducci, Lodovico ;
Al-Halawani, Hafez ;
Charu, Veena ;
Tam, Jennifer ;
Shahin, Seta ;
Dreiling, Lyndah ;
Ershler, William B. .
ONCOLOGIST, 2007, 12 (12) :1416-1424
[8]
Molecular insight in cancer treatment and prevention [J].
Balducci, Lodovico .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8) :1329-1336
[9]
Balducci Lodovico, 2005, J Natl Compr Canc Netw, V3, P572
[10]
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia [J].
Bennett, Charles L. ;
Silver, Samuel M. ;
Djulbegovic, Benjamin ;
Samaras, Athena T. ;
Blau, C. Anthony ;
Gleason, Kara J. ;
Barnato, Sara E. ;
Elverman, Kathleen M. ;
Courtney, D. Mark ;
McKoy, June M. ;
Edwards, Beatrice J. ;
Tigue, Cara C. ;
Raisch, Dennis W. ;
Yarnold, Paul R. ;
Dorr, David A. ;
Kuzel, Timothy M. ;
Tallman, Martin S. ;
Trifilio, Steven M. ;
West, Dennis P. ;
Lai, Stephen Y. ;
Henke, Michael .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08) :914-924